Leo Petrossian is the chief executive officer of Kandu Inc., a neurotechnology company formed from the merger of Neurolutions and Kandu Health. He is a seasoned health care executive and entrepreneur with deep expertise in bringing transformative medical devices from early development to commercialization.
Under his leadership, Neurolutions pioneered the IpsiHand, the first FDA-cleared, non-invasive brain-computer interface (BCI) for stroke rehabilitation and the first BCI to receive a Medicare reimbursement code. The company maintains resources for clinicians, a library of device tutorials, and a guide to getting started with IpsiHand. His work also appears in peer-reviewed research. Dr. Petrossian is passionate about advancing technologies that expand access, improve outcomes, and reshape standards of care in neurology and beyond.
He earned his MBA from the UCLA Anderson School of Management in 2014 and his PhD and MS in biomolecular nanotechnology and solid-state device physics as a National Science Foundation IGERT fellow at Arizona State University in 2007. He also holds a double BS in electrical engineering and biomedical engineering from California State University, Long Beach, and shares updates on LinkedIn.
For decades, stroke survivors have been told the same thing: Whatever function you haven’t recovered in six months, you likely never will. That assumption is now being dismantled. The American Stroke Association estimates that 1 in 4 American adults will experience stroke in their lifetime, often with devastating consequences. The 2011-2018 National Health and Nutrition Examination Survey estimated approximately 5.7 million U.S. adults living with at least one disability due …
Read more…
Is chronic stroke recovery really capped at 6 months?
